Summary:
In adolescents and young adults with type 1 diabetes, a 24-week low-carbohydrate (LC) or Mediterranean (MED) diet intervention significantly altered bone turnover markers (CTX and P1NP) compared to each other, though it was associated with variable effects on bone metabolism, indicating possible implications for bone health.
| PICO | Description |
|---|---|
| Population | Adolescents and young adults aged 12-21 years diagnosed with type 1 diabetes. |
| Intervention | Low-carbohydrate diet or Mediterranean diet followed for 24 weeks. |
| Comparison | Comparison between low-carbohydrate diet group and Mediterranean diet group, each with 20 participants. |
| Outcome | Significant changes in bone turnover markers: C-terminal telopeptide (CTX) and procollagen type 1 N-terminal propeptide (P1NP). Results suggest differential effects on bone metabolism by diet type, with potential clinical implications for bone health in type 1 diabetes. No severe adverse effects reported. |
Clinical Context
Type 1 diabetes is associated with increased fracture risk and impaired bone quality that develops early in the disease course, making adolescence and young adulthood critical periods for skeletal health optimization. The mechanisms underlying diabetic bone disease include hyperglycemia-induced advanced glycation end products accumulation in bone matrix, insulin deficiency affecting osteoblast function, and chronic inflammation. Dietary patterns significantly influence bone metabolism through multiple pathways including calcium and vitamin D intake, acid-base balance effects, and macronutrient-mediated hormonal responses. Low-carbohydrate diets have gained popularity in type 1 diabetes for glycemic benefits but raise theoretical concerns about bone health due to potential acid load from protein consumption and reduced fruit and grain intake. The Mediterranean diet emphasizes plant-based foods with demonstrated benefits for bone health in general populations. Understanding how these dietary patterns affect bone turnover markers in young people with type 1 diabetes has important implications for long-term skeletal outcomes during the critical period of peak bone mass accrual.
Clinical Pearls
- Both low-carbohydrate and Mediterranean diet interventions produced measurable changes in bone turnover markers (CTX and P1NP) over 24 weeks, demonstrating that dietary patterns can influence bone metabolism in type 1 diabetes.
- The differential effects between diet groups suggest that dietary macronutrient composition may have clinically relevant impacts on bone remodeling in this population.
- C-terminal telopeptide (CTX) reflects bone resorption activity while P1NP reflects bone formation, and the ratio of these markers indicates net bone balance.
- No severe adverse effects were reported with either dietary intervention, confirming the safety of structured dietary modification in adolescents and young adults with type 1 diabetes.
Practical Application
Clinicians advising young patients with type 1 diabetes on dietary approaches should consider potential bone health implications alongside glycemic effects. While specific directional findings from this study require further interpretation, the demonstration that different dietary patterns produce measurable bone turnover changes supports the importance of comprehensive nutritional assessment. For patients considering low-carbohydrate approaches for glycemic benefits, ensuring adequate calcium and vitamin D intake and monitoring bone health parameters may be prudent. The Mediterranean diet offers an alternative approach with established general health benefits that may be preferable for patients with bone health concerns. Collaboration between endocrinology, nutrition, and potentially bone health specialists may optimize dietary recommendations for young people with type 1 diabetes who are still accruing peak bone mass.
Broader Evidence Context
This study addresses an important gap in understanding the skeletal effects of popular dietary patterns in type 1 diabetes. Previous research has established that individuals with type 1 diabetes have elevated fracture risk despite often normal bone mineral density measurements, suggesting that bone quality rather than quantity drives the excess risk. Dietary factors are modifiable contributors to bone health that warrant investigation in this population. The findings complement literature on low-carbohydrate diet effects on bone in other populations, where results have been mixed depending on diet composition and study duration. The Mediterranean diet’s bone-favorable effects observed in general population studies provide context for interpreting comparative findings in type 1 diabetes.
Study Limitations
- The sample size of 20 participants per group limits statistical power to detect smaller between-group differences and perform subgroup analyses.
- Bone turnover markers serve as surrogate endpoints and do not directly measure bone density or fracture risk, the ultimate clinical outcomes of interest.
- The 24-week duration may not capture longer-term bone adaptations to dietary changes or clinical skeletal outcomes.
- Dietary adherence verification and specific macronutrient compositions achieved were not detailed in the summary.
- The specific direction and magnitude of bone marker changes for each diet were not specified, limiting clinical interpretation.
Bottom Line
Low-carbohydrate and Mediterranean diet interventions produce differential effects on bone turnover markers in adolescents and young adults with type 1 diabetes over 24 weeks. Clinicians should consider potential bone health implications when recommending dietary patterns to young patients with type 1 diabetes during this critical period for skeletal development.
Source: Levran, Neriya, et al. “Bone Turnover Markers (CTX and P1NP) Following Low-Carbohydrate and Mediterranean Diet Interventions in Adolescents and Young Adults with Type 1 Diabetes.” Read article here.
